Kestra Medical Technologies (KMTS) Research & Development (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Research & Development data on file, last reported at $5.0 million in Q1 2026.

• Research & Development for Q1 2026 came in at $5.0 million, up 48.29% year-over-year; the trailing twelve-month figure through Jan 2026 was $19.2 million (up 36.56% YoY), and the FY2025 annual result was $15.7 million, up 1.05% from the prior year.
• Research & Development improved to $5.0 million in Q1 2026 per KMTS's latest filing, from $4.9 million in the prior quarter.
• Over five years, Research & Development peaked at $5.4 million in Q2 2025 and troughed at $3.4 million in Q1 2025.
• A 3-year average of $4.1 million and a median of $3.8 million in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2025 and 2026: Research & Development decreased 10.23% in 2025, then soared 48.29% in 2026.
• A 3-year view of Research & Development shows it stood at $3.5 million in 2024, then jumped by 39.01% to $4.9 million in 2025, then advanced by 1.93% to $5.0 million in 2026.
• Business Quant data shows KMTS's Research & Development at $5.0 million in Q1 2026, $4.9 million in Q4 2025, and $4.0 million in Q3 2025.